IRAK4

STAINING OVERVIEW

? »

Overall cancer tissue 
staining statistics


0%
25%
50%
75%
100%

Tissue presentation order

Histological

Alphabetical

 

Antibody HPA000924

Antibody CAB016685

Antibody CAB022077

Tissue

Antibody staining

Antibody staining

Antibody staining

Colorectal cancer
Breast cancer
Prostate cancer
Ovarian cancer
Cervical cancer
Endometrial cancer
Carcinoid
Head and neck cancer
Thyroid cancer
Glioma
Lymphoma
Lung cancer
Melanoma
Skin cancer
Testis cancer
Urothelial cancer
Renal cancer
Stomach cancer
Pancreatic cancer
Liver cancer

Summary

Most malignant tissues were negative, or displayed faint cytoplasmic immunoreactivity. A single case of malignant lymphomas was strongly stained. Malignant tissues demonstrated moderate to strong cytoplasmic positivity. Malignancies generally exhibited moderate to strong cytoplasmic positivity often accompanied with distinct nucleolar staining. Most malignant melanomas, malignant gliomas, prostate, skin, lung and testicular cancers were weakly stained or negative.

Validation

Uncertain: Two (or more) antibodies yielding similar or partly similar staining patterns which are partly consistent with or contradicted by limited gene/protein characterization data
Uncertain: Two (or more) antibodies yielding dissimilar or partly similar staining patterns and there is no available gene/protein characterization data or only limited gene/protein characterization data
Supportive: Two (or more) antibodies yielding similar staining patterns which are partly consistent with gene/protein characterization data or consistent with limited gene/protein characterization data

Level of antibody staining/expression





High
Medium
Low
Not detected